Adjudication of new community pharmacies: comparison of ranking criteria

This article studies the differences between the models of candidate classification for the adjudication of new pharmacies in the different Spanish self-governing regions. The objective of this study is to analyze the profile of the selected professional. Generally, the ranking takes into account the professional activity as pharmacist, the pre-graduate formation as well as the postgraduate, with different weights. Some of the 15 autonomies include as merits the cooficial languages, an optional written test and special situations as unemployment. In general, the criteria try to find out the best profile of pharmacist based on the professional experience and the postgraduate formation

Potential impact of European decisions and reports in pharmacy planning in Spain

Currently there are several cases in the field of the European Union regarding Spanish legislation on private pharmacy planning. The first of these cases was initiated by issuing a reasoned opinion by the European Commission on 28 June 2006. The second approach has taken place through the various preliminary questions raised before the Court of Justice of the European Communities by certain Spanish courts. Although not all of the above procedures have been completed, certain European pronouncements do provide what might be the consequences that they may have on the Spanish legislation on the subject. It is very likely that the binomial property-ownership in favor of pharmacists and planning criteria established in the Spanish regulations is considered compatible with European law. On the contrary, it is feasible that certain aspects of the merit scales applied by the Autonomous Communities for awarding newly authorized community pharmacies must be changed

Effectiveness of an mHealth intervention combining a smartphone app and smart band on body composition in an overweight and obese population: Randomized controlled trial (EVIDENT 3 study)

Background: Mobile health (mHealth) is currently among the supporting elements that may contribute to an improvement in health markers by helping people adopt healthier lifestyles. mHealth interventions have been widely reported to achieve greater weight loss than other approaches, but their effect on body composition remains unclear. Objective: This study aimed to assess the short-term (3 months) effectiveness of a mobile app and a smart band for losing weight and changing body composition in sedentary Spanish adults who are overweight or obese. Methods: A randomized controlled, multicenter clinical trial was conducted involving the participation of 440 subjects from primary care centers, with 231 subjects in the intervention group (IG; counselling with smartphone app and smart band) and 209 in the control group (CG; counselling only). Both groups were counselled about healthy diet and physical activity. For the 3-month intervention period, the IG was trained to use a smartphone app that involved self-monitoring and tailored feedback, as well as a smart band that recorded daily physical activity (Mi Band 2, Xiaomi). Body composition was measured using the InBody 230 bioimpedance device (InBody Co., Ltd), and physical activity was measured using the International Physical Activity Questionnaire. Results: The mHealth intervention produced a greater loss of body weight (–1.97 kg, 95% CI –2.39 to –1.54) relative to standard counselling at 3 months (–1.13 kg, 95% CI –1.56 to –0.69). Comparing groups, the IG achieved a weight loss of 0.84 kg more than the CG at 3 months. The IG showed a decrease in body fat mass (BFM; –1.84 kg, 95% CI –2.48 to –1.20), percentage of body fat (PBF; –1.22%, 95% CI –1.82% to 0.62%), and BMI (–0.77 kg/m2, 95% CI –0.96 to 0.57). No significant changes were observed in any of these parameters in men; among women, there was a significant decrease in BMI in the IG compared with the CG. When subjects were grouped according to baseline BMI, the overweight group experienced a change in BFM of –1.18 kg (95% CI –2.30 to –0.06) and BMI of –0.47 kg/m2 (95% CI –0.80 to –0.13), whereas the obese group only experienced a change in BMI of –0.53 kg/m2 (95% CI –0.86 to –0.19). When the data were analyzed according to physical activity, the moderate-vigorous physical activity group showed significant changes in BFM of –1.03 kg (95% CI –1.74 to –0.33), PBF of –0.76% (95% CI –1.32% to –0.20%), and BMI of –0.5 kg/m2 (95% CI –0.83 to –0.19). Conclusions: The results from this multicenter, randomized controlled clinical trial study show that compared with standard counselling alone, adding a self-reported app and a smart band obtained beneficial results in terms of weight loss and a reduction in BFM and PBF in female subjects with a BMI less than 30 kg/m2 and a moderate-vigorous physical activity level. Nevertheless, further studies are needed to ensure that this profile benefits more than others from this intervention and to investigate modifications of this intervention to achieve a global effect

Note to the Spanish pharmacopoeia, IX edition: Acetanilide

We study the monograph "Acetanilide" of the current Spanish Pharmacopoeia, IX edition, comparatively with that included in foreign pharmacopoeias and propose modifications to it, based on theoretical considerations and experimental data

Shortages and irregular supply of medicines: an urgent problem.

Actualmente en el Estado español se están produciendo problemas en el suministro de medicamentos a los servicios farmacéuticos. En el presente artículo se revisa la normativa vigente acerca de la distribución de medicamentos. Se comentan además las posibles causas del problema. También se analizan los medios que desarrolla el Estado para evitar esta problemática y la postura de la Comunidad Valenciana que, de manera pionera, quiere regular en materia de distribución farmacéutica, mediante una normativa con rango de Ley, para evitar los problemas que se suscitan.In this paper, we discuss the problems arising from the current supply problems of medicines to pharmacy outlets in Spain, as well as a revision of present regulations governing their distribution. In addition to the possible causes, an analysis of the measures developed by the state to combat these problems has been made, as well as an assessment of the impact of new pioneering legislation passed by the regional government of Valencia, aimed at fi nding a solution

Mechanism and microkinetics of methanol synthesis via CO2 hydrogenation on indium oxide

Indium oxide has emerged as a highly effective catalyst for methanol synthesis by direct CO2 hydrogenation. Aiming at gathering a deeper fundamental understanding, mechanistic and (micro)kinetic aspects of this catalytic system were investigated. Steady-state evaluation at 5 MPa and variable temperature indicated a lower apparent activation energy for CO2 hydrogenation than for the reverse watergas shift reaction (103 versus 117 kJ mol!1), which is in line with the high methanol selectivity observed. Upon changing the partial pressure of reactants and products, apparent reaction orders of !0.1, 0.5, !0.2, and !0.9 were determined for CO2, H2, methanol, and water, respectively, which highlight a strong inhibition by the latter. Co-feeding of H2O led to catalyst deactivation by sintering for partial pressures exceeding 0.125 MPa, while addition of the byproduct CO to the gas stream could be favorable at a total pressure below 4 MPa but was detrimental at higher pressures. Density Functional Theory simulations conducted on In2O3(1 1 1), which was experimentally and theoretically shown to be the most exposed surface termination, indicated that oxygen vacancies surrounded by three indium atoms enable the activation of CO2 and split hydrogen heterolytically, stabilizing the polarized species formed. The most energetically favored path to methanol comprises three consecutive additions of hydrides and protons and features CH2OOH and CH2(OH)2 as intermediates. Microkinetic modeling based on the DFT results provided values for temperature and concentration-dependent parameters, which are in good agreement with the empirically obtained data. These results are expected to drive further optimization of In2O3-based materials and serve as a solid basis for reactor and process design, thus fostering advances towards a potential large-scale methanol synthesis from CO2

Genotype-phenotype correlations in valosin-containing protein disease: a retrospective muticentre study

Background Valosin-containing protein (VCP) disease, caused by mutations in the VCP gene, results in myopathy, Paget's disease of bone (PBD) and frontotemporal dementia (FTD). Natural history and genotype-phenotype correlation data are limited. This study characterises patients with mutations in VCP gene and investigates genotype-phenotype correlations. Methods Descriptive retrospective international study collecting clinical and genetic data of patients with mutations in the VCP gene. Results Two hundred and fifty-five patients (70.0% males) were included in the study. Mean age was 56.8 +/- 9.6 years and mean age of onset 45.6 +/- 9.3 years. Mean diagnostic delay was 7.7 +/- 6 years. Symmetric lower limb weakness was reported in 50% at onset progressing to generalised muscle weakness. Other common symptoms were ventilatory insufficiency 40.3%, PDB 28.2%, dysautonomia 21.4% and FTD 14.3%. Fifty-seven genetic variants were identified, 18 of these no previously reported. c.464G>A (p.Arg155His) was the most frequent variant, identified in the 28%. Full time wheelchair users accounted for 19.1% with a median time from disease onset to been wheelchair user of 8.5 years. Variant c.463C>T (p.Arg155Cys) showed an earlier onset (37.8 +/- 7.6 year) and a higher frequency of axial and upper limb weakness, scapular winging and cognitive impairment. Forced vital capacity (FVC) below 50% was as risk factor for being full-time wheelchair user, while FVC Conclusion This study expands the knowledge on the phenotypic presentation, natural history, genotype-phenotype correlations and risk factors for disease progression of VCP disease and is useful to improve the care provided to patient with this complex disease.Neurological Motor Disorder